Clinical Neuropsychopharmacology and Therapeutics
Online ISSN : 1884-8826
ISSN-L : 1884-8826
Original Contribution
A comparison of haloperidol plasma levels among Japanese, Korean and Swedish psychiatric patients
Sachiyo MoritaHyung-Keun RohKazutaka ShimodaToshiyuki SomeyaMorikazu ShibasakiGenta HirokaneJan-Olof SvenssonLeif Bertilsson
Author information

2010 Volume 1 Pages 24-31


Purpose: The purpose of this study is to compare the steady-state plasma levels of HAL between Japanese, Koreans and Swedes who were treated with HAL monotherapy per os.
Method: The steady-state plasma levels of haloperidol (HAL) in 75 Japanese, 120 Korean, and 50 Swedish psychiatric patients treated orally with HAL were compared.
Results: Significantly higher doses of HAL were used in the Koreans (mean dose = 21 mg/day) than in the Japanese (15 mg/day) or Swedes (9 mg/day) (one-way analysis of variance (ANOVA) (p<0.0001), Bonferroni's post test (p<0.001)). The mean concentration/daily dose ratio (C/D ratio) of HAL was 2.2 times higher in Korean patients (2.78 nmol/L/mg/day) and 1.5 times higher in Japanese patients (1.88 nmol/L/mg/day) than that in Swedish patients (1.24 nmol/L/mg/day). A significant difference in the C/D ratio was observed among the 3 ethnic groups (one-way ANOVA; p<0.0001).
Discussion: The higher C/D ratio of HAL in Asians might be partly due to the higher frequency of the CYP2D6*10 allele in Asians; however, interethnic differences in the activity of other enzymes, such as CYP3A4, might have caused the differences in the present study, especially at the higher doses of HAL.

Content from these authors
© 2010 The Japanese Society of Clinical Neuropsychopharmacology
Previous article Next article